Amgen Inc
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$465.45−0.56 (-0.12%)
Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%
Amgen GAAP Total Operating Expenses: $27,671M in FY2025, up 5.8% from a year earlier. That is the highest of the 9 years on record here.
Latest, FY2025
27,671
Period ended Dec 31, 2025
Change on a year earlier
+5.8%
26,166 in FY2024
History
9 years
Since FY2017
Sources
8
Documents cited below
Where the FY2025 figure comes from
“|| Total Operating Expenses | $ | 27,671 | $ | 26,166 | 6% | $ | 20,548 | $ | 18,396 | 12%”
Source: Form 8-K (amgn-20251231earningsrelea.htm, filed 2026-02-03) ↗
Reported in Form 8-K Reconciliations of GAAP to Non-GAAP Measures.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | GAAP Total Operating Expenses ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 27,671 | +5.8% | Form 8-K (amgn-20251231earningsrelea.htm, filed 2026-02-03) ↗ |
| FY2024 | Dec 31, 2024 | 26,166 | +28.9% | Form 8-K (amgn-20241231earningsrelea.htm, filed 2025-02-04) ↗ |
| FY2023 | Dec 31, 2023 | 20,293 | +21.1% | Form 8-K (amgn-20231231earningsrelea.htm, filed 2024-02-06) ↗ |
| FY2022 | Dec 31, 2022 | 16,757 | -8.6% | Form 8-K (amgn-20221231earningsrelea.htm, filed 2023-01-31) ↗ |
| FY2021 | Dec 31, 2021 | 18,340 | +12.6% | Form 8-K (amgenq42021earningsrelease.htm, filed 2022-02-07) ↗ |
| FY2020 | Dec 31, 2020 | 16,285 | +19.0% | Form 8-K (amgn-20201231xq4ex991.htm, filed 2021-02-02) ↗ |
| FY2019 | Dec 31, 2019 | 13,688 | +1.5% | Form 8-K (amgn-20191231xq4ex991.htm, filed 2020-01-30) ↗ |
| FY2018 | Dec 31, 2018 | 13,484 | +4.7% | Form 8-K (amgn-20181231xq4exhibit991.htm, filed 2019-01-29) ↗ |
| FY2017 | Dec 31, 2017 | 12,876 | – | Form 8-K (amgn-20181231xq4exhibit991.htm, filed 2019-01-29) ↗ |
Cite this data
StockData. (2026). Amgen GAAP Total Operating Expenses ($M), annual FY2017–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/gaap-opex-8k
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.